Kessler Foundation researchers showed that people with multiple sclerosis (MS) experience subtle language impairments that standard neuropsychological tests may incorrectly attribute to impaired executive functions. The article, ...
Apr 21, 2021
0
6
A survey of U.S. multiple sclerosis, or MS, specialist clinicians reveals the COVID-19 pandemic has created major changes in how they deliver care.
Apr 19, 2021
0
8
(HealthDay)—Women with pregnancy after versus before a multiple sclerosis (MS) diagnosis have fewer children and at an older age, according to a study published in the Feb. 1 issue of Multiple Sclerosis and Related Disorders.
Jan 13, 2021
0
2
(HealthDay)—The COVID-19 pandemic is having an impact on the psychological health of patients with relapsing-remitting multiple sclerosis (RRMS), according to a study published online July 21 in Multiple Sclerosis and Related ...
Aug 3, 2020
0
2
A new survey of more than 1,000 people with multiple sclerosis finds that an overwhelming majority use complementary and alternative medicine, with many using cannabis.
Jun 26, 2020
0
1
(HealthDay)—Cannabis use is common among multiple sclerosis (MS) patients with spasticity, according to a research letter published online Feb. 11 in Multiple Sclerosis and Related Disorders.
Feb 28, 2020
0
14
(HealthDay)—Timing of treatment start is an important predictor of disability accumulation in patients with pediatric-onset multiple sclerosis (MS), according to a study published online Jan. 17 in Multiple Sclerosis and ...
Jan 31, 2020
0
11
(HealthDay)—Comorbidities increase the rate of all-cause, but not multiple sclerosis (MS)-specific, hospital admissions among patients with MS, according to a study published online Jan. 21 in Multiple Sclerosis and Related ...
Jan 30, 2020
0
3
(HealthDay)—For pediatric patients with multiple sclerosis, there are more admissions among girls and among white children, according to a research letter published in the February 2020 issue of Multiple Sclerosis and Related ...
Dec 6, 2019
0
6
(HealthDay)—In a revised 2019 guideline, published in the January 2020 issue of Multiple Sclerosis and Related Disorders, updated recommendations from the Middle East North Africa Committee for Treatment and Research in ...
Nov 12, 2019
0
2
